• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.患者对基于初级保健办公室的丁丙诺啡/纳洛酮治疗的满意度。
J Gen Intern Med. 2007 Feb;22(2):242-5. doi: 10.1007/s11606-006-0050-y.
2
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.监禁史对基层医疗诊所用丁丙诺啡/纳洛酮治疗效果的影响。
J Gen Intern Med. 2010 Jul;25(7):670-4. doi: 10.1007/s11606-010-1306-0. Epub 2010 Mar 6.
3
Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.在意大利，双相丁丙诺啡/纳洛酮每两周一次与丁丙诺啡的临床经验：基于诊所有初步观察数据。
Clin Drug Investig. 2010;30 Suppl 1:33-9. doi: 10.2165/11536060-000000000-00000.
4
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years.在初级保健中使用丁丙诺啡/纳洛酮进行长期治疗：2至5年的结果。
Am J Addict. 2008 Mar-Apr;17(2):116-20. doi: 10.1080/10550490701860971.
5
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.咨询加丁丙诺啡-纳洛酮维持疗法治疗阿片类药物依赖。
N Engl J Med. 2006 Jul 27;355(4):365-74. doi: 10.1056/NEJMoa055255.
6
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.接受诊室美沙酮/纳洛酮治疗的阿片类药物依赖患者中可卡因使用与治疗结局的关系。
Am J Addict. 2010 Jan-Feb;19(1):53-8. doi: 10.1111/j.1521-0391.2009.00003.x.
7
Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence.丁丙诺啡/纳洛酮贴膜和片剂配方疗法在阿片类药物依赖成人中的持续性及医疗保健利用情况
J Med Econ. 2014 Sep;17(9):626-36. doi: 10.3111/13696998.2014.925463. Epub 2014 Jun 6.
8
Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.在社区基层医疗环境中使用丁丙诺啡-纳洛酮治疗阿片类药物成瘾。
Ann Fam Med. 2007 Mar-Apr;5(2):146-50. doi: 10.1370/afm.665.
9
Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder.开始接受阿片类物质使用障碍治疗的个体中丁丙诺啡/纳洛酮剂量与疼痛强度的关系
J Subst Abuse Treat. 2015 Jan;48(1):128-31. doi: 10.1016/j.jsat.2014.09.007. Epub 2014 Sep 26.
10
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.基层医疗办公室布托啡诺治疗：海洛因依赖患者与处方阿片类药物依赖患者的比较
J Gen Intern Med. 2007 Apr;22(4):527-30. doi: 10.1007/s11606-007-0129-0.

引用本文的文献

1
Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial.基于办公室的阿片类药物治疗中疼痛自我管理及以患者为导向的丁丙诺啡剂量调整用于疼痛控制和维持治疗的研究方案：一项1型混合、2×2析因随机对照试验
Subst Use Addctn J. 2025 Jan;46(1):201-207. doi: 10.1177/29767342241261562. Epub 2024 Jun 22.
2
Recent modifications to the US methadone treatment system are a Band-Aid-not a solution-to the nation's broken opioid use disorder treatment system.美国美沙酮治疗系统最近的调整只是权宜之计，而非解决该国支离破碎的阿片类药物使用障碍治疗系统的办法。
Health Aff Sch. 2023 Jun 20;1(1):qxad018. doi: 10.1093/haschl/qxad018. eCollection 2023 Jul.
3
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population.以简短干预、药物和 CBT4CBT 促进住院后酒精治疗参与：在多样化患者群体中进行的随机临床试验方案。
Addict Sci Clin Pract. 2023 Sep 19;18(1):55. doi: 10.1186/s13722-023-00407-9.
4
Perspectives on contingency management for alcohol use and alcohol-associated conditions among people in care with HIV.关于对感染艾滋病毒的受护理者的酒精使用及酒精相关状况进行应急管理的观点
Alcohol Clin Exp Res (Hoboken). 2023 Sep;47(9):1783-1797. doi: 10.1111/acer.15159. Epub 2023 Aug 29.
5
Involvement of people who use alcohol and other drug services in the development of patient-reported measures of experience: A scoping review.参与酒精和其他药物服务的人群在开发患者报告的体验衡量指标中的作用：范围综述。
Health Expect. 2023 Dec;26(6):2151-2163. doi: 10.1111/hex.13829. Epub 2023 Jul 29.
6
A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care.对美国将药物使用治疗服务纳入主流医疗保健的障碍和促进因素的范围审查。
Drug Alcohol Depend Rep. 2023 Mar 24;7:100152. doi: 10.1016/j.dadr.2023.100152. eCollection 2023 Jun.
7
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial.患者对标准美沙酮和灵活丁丙诺啡/纳洛酮护理模式的满意度：来自一项实用随机对照临床试验的结果。
J Addict Med. 2023;17(1):e49-e56. doi: 10.1097/ADM.0000000000001048. Epub 2022 Aug 2.
8
Health-related quality of life in outpatients with substance use disorder: evolution over time and associated factors.物质使用障碍患者的健康相关生活质量：随时间的演变及相关因素。
Health Qual Life Outcomes. 2022 Feb 16;20(1):26. doi: 10.1186/s12955-022-01935-9.
9
Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale.在减少伤害机构进行现场丁丙诺啡诱导以增加治疗参与度和降低 HIV 风险：设计和原理。
Contemp Clin Trials. 2022 Mar;114:106674. doi: 10.1016/j.cct.2021.106674. Epub 2022 Jan 3.
10
Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients.舌下含服丁丙诺啡/纳洛酮及高危慢性疼痛患者的多模式管理
J Clin Med. 2021 Mar 2;10(5):973. doi: 10.3390/jcm10050973.

本文引用的文献

1
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.咨询加丁丙诺啡-纳洛酮维持疗法治疗阿片类药物依赖。
N Engl J Med. 2006 Jul 27;355(4):365-74. doi: 10.1056/NEJMoa055255.
2
Provider satisfaction with office-based treatment of opioid dependence: a systematic review.医疗服务提供者对基于办公室的阿片类药物依赖治疗的满意度：一项系统评价。
Subst Abus. 2005 Mar;26(1):15-22. doi: 10.1300/j465v26n01_02.
3
Functional status and patient satisfaction: a comparison of ischemic heart disease, obstructive lung disease, and diabetes mellitus.功能状态与患者满意度：缺血性心脏病、阻塞性肺病和糖尿病的比较。
J Gen Intern Med. 2005 May;20(5):452-9. doi: 10.1111/j.1525-1497.2005.40057.x.
4
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?基于办公室的丁丙诺啡治疗阿片类药物依赖的实践：它与新患者开始治疗有关吗？
Drug Alcohol Depend. 2005 Jul;79(1):113-6. doi: 10.1016/j.drugalcdep.2004.12.008.
5
Continuity of care and other determinants of patient satisfaction with primary care.初级保健的连续性护理及患者满意度的其他决定因素。
J Gen Intern Med. 2005 Mar;20(3):226-33. doi: 10.1111/j.1525-1497.2005.40135.x.
6
Relationship between drug treatment services, retention, and outcomes.药物治疗服务、留治率与治疗结果之间的关系。
Psychiatr Serv. 2004 Jul;55(7):767-74. doi: 10.1176/appi.ps.55.7.767.
7
A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain.西班牙美沙酮治疗中心阿片类药物依赖患者满意度调查。
Drug Alcohol Depend. 2004 Mar 8;73(3):307-13. doi: 10.1016/j.drugalcdep.2003.11.001.
8
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.使用丁丙诺啡和纳洛酮舌下片剂配方在门诊治疗阿片类药物成瘾。
N Engl J Med. 2003 Sep 4;349(10):949-58. doi: 10.1056/NEJMoa022164.
9
Treatment of heroin dependence with buprenorphine in primary care.
Am J Drug Alcohol Abuse. 2002;28(2):231-41. doi: 10.1081/ada-120002972.
10
Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients?
J Subst Abuse Treat. 2001 Oct;21(3):135-44. doi: 10.1016/s0740-5472(01)00189-1.

患者对基于初级保健办公室的丁丙诺啡/纳洛酮治疗的满意度。

Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.

作者信息

Barry Declan T, Moore Brent A, Pantalon Michael V, Chawarski Marek C, Sullivan Lynn E, O'Connor Patrick G, Schottenfeld Richard S, Fiellin David A

机构信息

Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519-1187, USA,

出版信息

J Gen Intern Med. 2007 Feb;22(2):242-5. doi: 10.1007/s11606-006-0050-y.

DOI:10.1007/s11606-006-0050-y
PMID:17356993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1824745/
Abstract

BACKGROUND

Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown.

OBJECTIVE

To identify factors related to patient satisfaction in patients receiving primary care-based buprenorphine/naloxone that varied in counseling intensity (20 vs 45 minutes) and office visit frequency (weekly vs thrice weekly).

DESIGN AND PARTICIPANTS

One hundred and forty-two opioid-dependent subjects.

MEASUREMENTS

Demographics, drug treatment history, and substance use status at baseline and during treatment were collected. The primary outcome was patient satisfaction at 12 weeks.

RESULTS

Patients' mean overall satisfaction score was 4.4 (out of 5). Patients were most satisfied with the medication and ancillary services and indicated strong willingness to refer a substance-abusing friend for the same treatment. Patients were least satisfied with their interactions with other opioid-dependent patients, referrals to Narcotics Anonymous, and the inconvenience of the treatment location. Female gender (beta = .17, P = .04) and non-White ethnicity/race (beta = .17, P = .04) independently predicted patient satisfaction. Patients who received briefer counseling and buprenorphine/naloxone dispensed weekly had greater satisfaction than those whose medication was dispensed thrice weekly (mean difference 4.9, 95% confidence interval 0.08 to 9.80, P = .03).

CONCLUSIONS

Patients are satisfied with primary care office-based buprenorphine/naloxone. Providers should consider the identified barriers to patient satisfaction.

摘要

背景

接受基于初级保健的丁丙诺啡/纳洛酮治疗的患者满意度相关因素尚不清楚。

目的

确定接受基于初级保健的丁丙诺啡/纳洛酮治疗的患者的满意度相关因素，这些因素在咨询强度（20分钟与45分钟）和门诊就诊频率（每周一次与每周三次）方面存在差异。

设计与参与者

142名阿片类药物依赖受试者。

测量

收集基线及治疗期间的人口统计学资料、药物治疗史和物质使用状况。主要结局是12周时的患者满意度。

结果

患者的平均总体满意度得分为4.4（满分5分）。患者对药物和辅助服务最满意，并表示非常愿意将滥用药物的朋友推荐接受同样的治疗。患者对与其他阿片类药物依赖患者的互动、转介至匿名戒毒会以及治疗地点的不便最不满意。女性（β = 0.17，P = 0.04）和非白人种族（β = 0.17，P = 0.04）独立预测患者满意度。接受简短咨询且每周一次给予丁丙诺啡/纳洛酮的患者比每周三次给予药物的患者满意度更高（平均差异4.9，95%置信区间0.08至9.80，P = 0.03）。

结论

患者对基于初级保健机构的丁丙诺啡/纳洛酮治疗感到满意。医疗服务提供者应考虑已确定的影响患者满意度的障碍因素。